GPX Medical AB (publ) kommer att presentera på Aktieportföljen Live den 24 november 2021, kl. 13.35. Med en övertecknad företrädesemission i ryggen och nya storägare ombord presenterar vd Hanna Sjöström den senaste utvecklingen i bolaget och blickar framåt mot ett händelserikt kommande år.  

Följ presentationen i direktsändning via Direkt Studios på denna länk: https://www.youtube.com/watch?v=Dd8UCMCZDNs

Läs pressmeddelandet i sin helhet här: Pressmeddelande

About GPX Medical

GPX Medical AB (publ) is revolutionizing neonatal intensive care with NEOLA®, a medical device that can offer continuous lung monitoring and real-time alerts of life-threatening complications using a cutting-edge technology that measures lung volume changes and oxygen gas concentration. NEOLA® has the potential to provide better care, fewer days in intensive care and healthier lives for preterm born infants. Founded in 2016 and headquartered in Lund, Sweden, GPX Medical is building on a historic Swedish legacy of medical technology innovation and invaluable contributions to global health care.

For investors

Please contact CEO Hanna Sjöström for investment opportunities:
hanna.sjostrom@gpxmedical.se

Contact

GPX Medical AB (publ)
Ideon Science Park
Scheelevägen 27
223 63 Lund
info@gpxmedical.se

Organization number: 559069-9012